All Brands Owned by Caleres

Is Caleres publicly traded?
Yes, Caleres, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol CAL. Investors can purchase shares through any brokerage account that provides access to NYSE-listed stocks.

What is Caleres's old name?
Caleres was formerly known as the Brown Shoe Company, a name it used from 1913 until rebranding as Caleres in 2015. The company was originally founded in 1878 as Bryan, Brown and Company by George Warren Brown in St. Louis, Missouri.

When did Caleres acquire Stuart Weitzman?
Caleres completed the acquisition of Stuart Weitzman from Tapestry, Inc. on August 4, 2025, for $120.2 million, including $11.5 million in cash received at closing. The net purchase price was $108.7 million. Stuart Weitzman generated trailing 12-month sales of approximately $220 million at the time of acquisition and brought 73 retail locations, including 23 in North America and 50 in China.

What brands does Caleres own?
Caleres owns Famous Footwear (retail chain), Sam Edelman, Allen Edmonds, Naturalizer, Vionic, Dr. Scholl's, and Stuart Weitzman. These brands operate through two segments: Famous Footwear (retail) and Brand Portfolio (owned brands sold through wholesale, direct-to-consumer, and e-commerce).

What is Caleres's annual revenue?
Caleres reported net sales of $2.8 billion for fiscal 2025 (52 weeks ended January 31, 2026), an increase of 1.3% from fiscal 2024. The acquisition of Stuart Weitzman contributed $102.2 million in sales during the year. On an organic basis, excluding Stuart Weitzman, sales declined 2.5%. For Q1 2026, net sales were $667 million, up 8.5% from Q1 2025.

Who is the CEO of Caleres?
Jay Schmidt serves as President and CEO of Caleres. He has identified three strategic growth vectors: owned e-commerce, international expansion, and lead brand development. Schmidt described 2026 as a "build-back year" with modest organic sales growth and meaningful earnings recovery.

How is Caleres performing in 2026?
For Q1 2026, Caleres reported net sales of $667 million, up 8.5% from Q1 2025. Brand Portfolio sales increased 20.6% with organic sales up 5.8%. GAAP earnings per diluted share were $0.42 and adjusted earnings per diluted share were $0.38, both exceeding guidance. Gross margin improved 200 basis points to 47.3%. For full-year 2026, Caleres expects total sales to increase low to mid-single digits with GAAP EPS of $1.44 to $1.69.